Japan PM’s advisers urge annual review of drug prices

Prime Minister Shinzo Abe’s economic advisers, hoping to curb Japan’s ballooning healthcare costs, proposed on Wednesday reforms to the way drug prices are set, a step opposed by foreign and domestic drug makers who say the changes will stifle investment.

Japan announced its plan to step up the pace and expand the scope of drug price reviews, one of the most aggressive measures it is taking to rein in ballooning healthcare costs for a rapidly ageing nation.

The plans, which follow drastic price cuts for two blockbuster drugs, have been opposed by drugmakers worried about hits to revenue and who argue that frequent reviews will stifle investment by creating greater uncertainty over pricing.

For more information, read the full articles here:

Tagged with

Published 28. December 2016 in News Japan